Congenital Heart Disease and Noncompaction Cardiomyopathy Flashcards

1
Q

What is noncompaction cardiomyopathy (NCCM)?

A

A genetic cardiomyopathy characterized by an abnormal structure of the heart muscle, often diagnosed in adulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the prevalence of NCCM?

A

Approximately 0.14%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which congenital heart disease is most commonly associated with NCCM?

A

Ebstein anomaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are common congenital heart diseases associated with NCCM?

A
  • Ebstein anomaly
  • Aortic coarctation
  • Tetralogy of Fallot
  • Bicuspid aortic valve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What diagnostic methods are used for NCCM?

A
  • Transthoracic echocardiography
  • Cardiac MRI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the diagnostic ratio for NCCM using echocardiography?

A

Greater than 2:1 at the end of diastole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or False: NCCM can be present from birth.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Ebstein anomaly?

A

A malformation of the tricuspid valve characterized by the displacement of the tricuspid leaflets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What complications are associated with Ebstein anomaly?

A
  • Cyanosis
  • Right-sided heart failure
  • Arrhythmias
  • Sudden cardiac death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the common clinical presentations of NCCM?

A
  • Heart failure
  • Supraventricular arrhythmias
  • Ventricular arrhythmias
  • Sudden cardiac death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are common treatments for NCCM?

A
  • Beta-blockers
  • Angiotensin-converting enzyme (ACE) inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the recommended follow-up for asymptomatic patients with preserved LV function?

A

Annual or biannual cardiologic follow-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fill in the blank: The main diagnostic modality for Ebstein anomaly is _______.

A

Transthoracic echocardiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the risk associated with patients having both Bicuspid aortic valve (BAV) and NCCM?

A

Increased risk for heart failure, arrhythmias, thromboembolic events, and sudden cardiac death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the relationship between sarcomere gene mutations and NCCM?

A

Similar mutations found in patients with Ebstein anomaly suggest a genetic predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is pseudo-NCCM?

A

Heavily trabeculated myocardium that can be confused with NCCM, such as in congenitally corrected transposition of the great arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the significance of longitudinal studies on unaffected carriers of pathogenic mutations?

A

To provide insight into whether noncompaction may develop later in life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the challenges faced by patients with congenital heart disease (CHD) and NCCM?

A

Multiple previous surgical interventions and potential for heart failure and life-threatening arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the recommended approach for anticoagulation therapy in NCCM?

A

Advised only in patients with ejection fraction less than 40%, atrial fibrillation, or previous thrombo-embolic events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

True or False: Thromboembolic events are common in NCCM.

21
Q

What is the importance of awareness among clinicians regarding NCCM?

A

To ensure early diagnosis and management in patients with congenital heart disease

22
Q

What does the term ‘cardiac morphogenesis’ refer to?

A

The development of the heart’s structure during fetal growth, potentially influenced by sarcomere defects

23
Q

What is the recommended diagnostic ratio for NCCM using MRI?

A

Greater than 2.3 at the end of diastole

24
Q

What is the incidence of Ebstein anomaly?

A

Approximately 1 in 200,000 live births

25
What is the significance of the MYH7 mutation in patients with NCCM?
It has been reported in sporadic patients and families with NCCM and Ebstein anomaly
26
Which congenital heart disease is most commonly associated with NCCM?
Ebstein anomaly
27
What are common congenital heart diseases associated with NCCM?
* Ebstein anomaly * Aortic coarctation * Tetralogy of Fallot * Bicuspid aortic valve
28
What diagnostic methods are used for NCCM?
* Transthoracic echocardiography * Cardiac MRI
29
What is the diagnostic ratio for NCCM using echocardiography?
Greater than 2:1 at the end of diastole
30
True or False: NCCM can be present from birth.
True
31
What is Ebstein anomaly?
A malformation of the tricuspid valve characterized by the displacement of the tricuspid leaflets
32
What complications are associated with Ebstein anomaly?
* Cyanosis * Right-sided heart failure * Arrhythmias * Sudden cardiac death
33
What are the common clinical presentations of NCCM?
* Heart failure * Supraventricular arrhythmias * Ventricular arrhythmias * Sudden cardiac death
34
What are common treatments for NCCM?
* Beta-blockers * Angiotensin-converting enzyme (ACE) inhibitors
35
What is the recommended follow-up for asymptomatic patients with preserved LV function?
Annual or biannual cardiologic follow-up
36
Fill in the blank: The main diagnostic modality for Ebstein anomaly is _______.
Transthoracic echocardiography
37
What is the risk associated with patients having both Bicuspid aortic valve (BAV) and NCCM?
Increased risk for heart failure, arrhythmias, thromboembolic events, and sudden cardiac death
38
What is the relationship between sarcomere gene mutations and NCCM?
Similar mutations found in patients with Ebstein anomaly suggest a genetic predisposition
39
What is pseudo-NCCM?
Heavily trabeculated myocardium that can be confused with NCCM, such as in congenitally corrected transposition of the great arteries
40
What is the significance of longitudinal studies on unaffected carriers of pathogenic mutations?
To provide insight into whether noncompaction may develop later in life
41
What are the challenges faced by patients with congenital heart disease (CHD) and NCCM?
Multiple previous surgical interventions and potential for heart failure and life-threatening arrhythmias
42
What is the recommended approach for anticoagulation therapy in NCCM?
Advised only in patients with ejection fraction less than 40%, atrial fibrillation, or previous thrombo-embolic events
43
True or False: Thromboembolic events are common in NCCM.
False
44
What is the importance of awareness among clinicians regarding NCCM?
To ensure early diagnosis and management in patients with congenital heart disease
45
What does the term 'cardiac morphogenesis' refer to?
The development of the heart's structure during fetal growth, potentially influenced by sarcomere defects
46
What is the recommended diagnostic ratio for NCCM using MRI?
Greater than 2.3 at the end of diastole
47
What is the incidence of Ebstein anomaly?
Approximately 1 in 200,000 live births
48
What is the significance of the MYH7 mutation in patients with NCCM?
It has been reported in sporadic patients and families with NCCM and Ebstein anomaly